✅ Clinical benchmark for IMT Delighted to share I will now be taking up an Academic Clinical Fellowship in Medical Oncology @UniofNewcastle starting Aug 2023!🔬 Very grateful to the excellent mentors and colleagues who have made this possible from AFP FY2 @Newcastle_ECMC 🧬

Hugely grateful for this opportunity and can’t wait to get started!

Thank you for spreading the word - and thank you to @sarahaftonrae for amazing cooperation across our sites in the North. #clincialtrials #equityofaccess

📢Student Nurses we need your expertise😎We are creating an e-learning course 4 Student Nurses around the role of a Clinical Research Nurse. Cud U complete a "Very" short survey 2 support this project 🙏Plz RT @NorthumbriaUni @sunderlanduni ⏩ https://t.co/DIU5laL8Qb⏪

PGCert in Clinical Research with Distinction from @UniofNewcastle ✅ Great to consolidate knowledge in academic writing, governance and study design as part of ACF Year 1. Looking forward to what comes next!

We're so proud of Ben, Karen, and all the young people who worked together to make this website possible 👏 Find out more about how the website hopes to demystify clinical trials for young people and teenagers with cancer 👉 https://t.co/vAD6jbBu5r @Newcastle_NHS

Really insightful paper from the Newcastle and Manchester ECMCs @ECMC_UK Lots to think about in terms of future steps to address this issue! 💭

Important work on access the early phase oncology trials @ECMC_UK ▶️ efforts required to improve access ▶️ need to apply this work to later phase trials

Well done @sarahaftonrae and @SammyShaya fantastic to see this published. @ECMC_UK @ECMC_Manchester @TheChristieNHS @MCRCnews 👇🏻

@sarahaftonrae It's been a pleasure working with you. Here's to the next one. 🚨 Being in a poorer socioeconomic demographic reduces likelihood of referral for early phase trials in North England. 🚨 Living far away from trial centre reduces referral https://t.co/6BQwnVvvsC

Thinking forward 💭 ➡️ How do we improve access to trials? ➡️ What are the implications of this in generalisability of results? ➡️ How do we measure this at a national level?

Massive thank you to everyone who contributed to this great collaborative work. Specifically @SammyShaya for co-leading on this from Manchester and then Australia! @AlastairGreyst2 @oncocook @OingC1 @iamdonnagraham @Newcastle_ECMC @ECMC_Manchester (+ many others not on X)

Happy to share Newcastle and Manchester ECMC joint publication looking at access to early phase trials in oncology 📄 https://t.co/aQrxatQgAJ 📌 Inequalities in socioeconomic and geographic factors influence referral and enrolment to early phase clinical trials

BONUS Global Oncology Conference is happening now! Join us and our speakers here: https://t.co/cOM2gaj5E6 @SusannahStanwa1 @davidcwedge @sbomken @sarahaftonrae @michaelroweuk2 @prerana001 @J_Kucharczak @pao_adventures

🗣️ Join us for @NHIPartners Fellows Forum 22nd May for Cultural Competency training organised with @ConnectedVoice_ Delighted to have been a part of planning this and looking forward to the next few months of developments in EDI! https://t.co/EHJTuJzTin

Panel Speaker Annoucement: Dr Sarah Rae, Academic Clinical Fellow in Medical Oncology - @sarahaftonrae Join us at BONUS conference on Saturday 9th March, 2024. https://t.co/cOM2gaj5E6

We at BONUS want to welcome you to our *FREE virtual* conference on *Global Health in Oncology*, held on the *9th of March*😇 *SIGN UP* at: https://t.co/cOM2gaj5E6 **Certificates will be provided!** Sponsored by MDU and BACR

🚨There is still time to register for our March Lightning Talk. Join Dr @niinamk and @ProfJohnIsaacs to discuss the importance of being supported throughout your academic career pathway, especially as an early career researcher. #NHIPAcademy

Our poster on experience pooling control arms within a complex phase I drug-RT platform trial at #ESMOTAT24 @LeedsCTRU

Building the team @DrMirallas @myESMO #ESMOTAT24 @sarahaftonrae

Recruiting for tomorrow morning..? #ESMOTAT24